Back to Authors

Lehtinen, PL Kellokumpu

A5016549223 | I4210126318

Mayo Clinic

Tampere University Hospital

Citations 1

Primary outcome analysis of invasive disease-free survival for monarchE: abemaciclib plus adjuvant endocrine therapy for high-risk early breast cancer

Senologie - Zeitschrift für Mammadiagnostik und -therapie | June 11, 2021 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1055/s-0041-1730206